Abbott Wins Unrestricted Use Of Stent Patent

Law360, New York (August 8, 2007, 12:00 AM EDT) -- A federal judge has adopted Abbott Laboratories’s interpretation of its settlement of a coronary stent patent dispute with Medinol Ltd., finding that Abbott may exploit the patent however it pleases rather than just to manufacture a specific product.

Judge Shira A. Scheindlin of the U.S. District Court for the Southern District of New York on Tuesday granted Abbott’s motion to enforce the settlement and denied Medinol’s. Abbott had argued that the settlement’s licensing arrangement was unrestricted regarding the patent’s use, while Medinol said the deal was...
To view the full article, register now.